Published in J Neurol Neurosurg Psychiatry on September 01, 1983
Autonomic Nervous System Dysfunction in Parkinson's Disease. Curr Treat Options Neurol (2003) 0.88
Management of overactive bladder syndrome. Postgrad Med J (2007) 0.82
Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol (2016) 0.78
Bladder, Bowel, and Sexual Dysfunction in Multiple Sclerosis. Curr Treat Options Neurol (2001) 0.78
Uses of complementary and alternative medicine in multiple sclerosis. J Tradit Complement Med (2014) 0.77
[Not Available]. Can Fam Physician (1991) 0.75
Anti-diuresis in the management of daytime urinary -incontinence. Facts Views Vis Obgyn (2009) 0.75
The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. Br J Urol (1982) 2.15
The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol Suppl (1988) 3.12
Incidence of pregnancy after laparoscopy and hydrotubation. Br Med J (Clin Res Ed) (1982) 3.11
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol (2001) 3.05
Posterior colporrhaphy: its effects on bowel and sexual function. Br J Obstet Gynaecol (1997) 3.00
Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up. BJOG (2007) 2.85
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients. J Clin Microbiol (2001) 2.45
The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. Br J Urol (1982) 2.15
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. Antimicrob Agents Chemother (1999) 2.08
The surgical management of vaginal vault prolapse. Br J Obstet Gynaecol (1991) 2.03
Burch colposuspension: a 10-20 year follow up. Br J Obstet Gynaecol (1995) 2.00
Vaginal cones: a conservative method of treating genuine stress incontinence. Br J Obstet Gynaecol (1988) 1.95
Distress and delay associated with urinary incontinence, frequency, and urgency in women. BMJ (1988) 1.86
Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting. AIDS (1999) 1.85
High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire. J Acquir Immune Defic Syndr (2001) 1.71
Urethral pressure measurement by microtransducer: the results in symptom-free women and in those with genuine stress incontinence. Br J Obstet Gynaecol (1983) 1.65
Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel. AIDS (2000) 1.53
The colposuspension operation for urinary incontinence. Br J Obstet Gynaecol (1976) 1.51
Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples. AIDS (2000) 1.43
Primary repair of obstetric anal sphincter rupture using the overlap technique. Br J Obstet Gynaecol (1999) 1.41
Psychiatric aspects of urinary incontinence in women attending an outpatient urodynamic clinic. BMJ (1990) 1.40
Combined laparoscopic and micro-laparotomy removal of benign cystic teratomata. Br J Obstet Gynaecol (1993) 1.39
Doctors leaving the training grades in obstetrics and gynaecology: a study of the years 1985 to 1988. Br J Obstet Gynaecol (1996) 1.39
[Virological evaluation of treating HIV-infected patients with (combinations of) antiretroviral drugs at the Amsterdam Academic Medical Center, 1996/'97]. Ned Tijdschr Geneeskd (1998) 1.39
A comparison of bladder neck movement and elevation after tension-free vaginal tape and colposuspension. BJOG (2000) 1.38
Laparoscopic colposuspension. Br J Obstet Gynaecol (1998) 1.38
Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int (2000) 1.28
Caffeine: does it affect your bladder? Br J Urol (1990) 1.27
Micturition and the mind: psychological factors in the aetiology and treatment of urinary symptoms in women. Br Med J (Clin Res Ed) (1987) 1.26
Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: association with therapy failure. J Infect Dis (1998) 1.26
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters. Proc Natl Acad Sci U S A (2001) 1.26
Pelvic floor dysfunction in women after pelvic trauma. BJOG (2004) 1.26
Algorithmic method for assessing urinary incontinence in elderly women. Br Med J (Clin Res Ed) (1981) 1.25
The pelvic floor sequelae of childbirth. Br J Hosp Med (1996) 1.24
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure. AIDS (2000) 1.23
Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type 1 mutants. J Virol (2001) 1.20
Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples. Nucleosides Nucleotides Nucleic Acids (2001) 1.19
Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. Virus Genes (2001) 1.16
Clinical and urodynamic features of failed incontinence surgery in the female. Obstet Gynecol (1978) 1.16
The incidence of urological symptoms in normal pregnancy. Br J Obstet Gynaecol (1980) 1.15
Ambulatory monitoring and conventional cystometry in asymptomatic female volunteers. Br J Obstet Gynaecol (1996) 1.15
A comparison of vaginal and suprapubic surgery in the correction of incontience due to urethral sphincter incompetence. Br J Urol (1979) 1.14
Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up. Antivir Ther (2001) 1.14
Idiopathic bladder instability treated by biofeedback. Br J Urol (1978) 1.14
Preserving the pelvic floor and perineum during childbirth--elective caesarean section? Br J Obstet Gynaecol (1996) 1.13
Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor loviride. Antimicrob Agents Chemother (1998) 1.12
A clinical and urodynamic assessment of the Burch colposuspension for genuine stress incontinence. Br J Obstet Gynaecol (1983) 1.11
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen. AIDS (2000) 1.10
Evaluation of flurbiprofen in detrusor instability. Br Med J (1980) 1.10
The incidence of genital prolapse after the Burch colposuspension. Am J Obstet Gynecol (1992) 1.10
Tension-free vaginal tape for primary genuine stress incontinence: a two-centre follow-up study. BJU Int (2000) 1.09
Anal function: effect of pregnancy and delivery. Am J Obstet Gynecol (2001) 1.06
Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study. Br J Urol (1998) 1.05
Ambulatory urodynamic monitoring. Br J Obstet Gynaecol (1996) 1.05
Antenatal prediction of postpartum urinary and fecal incontinence. Obstet Gynecol (1999) 1.05
Periurethral collagen injections for genuine stress incontinence: a 2-year follow-up. Br J Urol (1995) 1.04
Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART. Virology (2000) 1.03
Hyponatraemia and severity and outcome of myocardial infarction. Br Med J (1979) 1.03
Sacrohysteropexy with synthetic mesh for the management of uterovaginal prolapse. BJOG (2001) 1.02
HIV drug susceptibility and treatment response to mega-HAART regimen in patients from the Frankfurt HIV cohort. Antivir Ther (2000) 1.01
Surgical treatment of incontinence in elderly women. Surg Gynecol Obstet (1980) 1.01
A follow up of silastic sling for genuine stress incontinence. Br J Obstet Gynaecol (1995) 1.01
Voiding difficulties in the female: prevalence, clinical and urodynamic review. Obstet Gynecol (1983) 1.00
Techniques of rectocele repair and their effects on bowel function. Int Urogynecol J Pelvic Floor Dysfunct (1998) 0.99
The objective study of incontinence after repair operations. Surg Gynecol Obstet (1973) 0.98
Detrusor instability following surgery for genuine stress incontinence. Br J Urol (1979) 0.97
Lateral bead-chain urethrocystography after successful and unsuccessful colposuspension. Br J Obstet Gynaecol (1985) 0.97
Correlation of urethral closure pressure, leak-point pressure and incontinence severity measures. Int Urogynecol J Pelvic Floor Dysfunct (2001) 0.96
Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid. J Acquir Immune Defic Syndr (2001) 0.96
Sacrocolpopexy: a retrospective study of a clinician's experience. Br J Obstet Gynaecol (1994) 0.96
Urological complications of traumatic diastasis of the symphysis pubis in the female. Br J Urol (1981) 0.95
The use of intravaginal oestrogen cream in genuine stress incontinence. Br J Obstet Gynaecol (1983) 0.95
Urodynamics: prediction, outcome and analysis of mechanism for cure of stress incontinence by periurethral collagen. Br J Obstet Gynaecol (1997) 0.95
Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers. Xenobiotica (1992) 0.94
Psychological aspects of 211 female patients attending a urodynamic unit. J Psychosom Res (1991) 0.93
Vault prolapse and rectocele: assessment of repair using sacrocolpopexy with mesh interposition. BJOG (2000) 0.92
Resistance profiles in patients with viral rebound on potent antiretroviral therapy. J Infect Dis (2000) 0.92
Genuine stress incontinence and detrusor instability--a review of 200 patients. Br J Obstet Gynaecol (1980) 0.92
The ethnic cultural and social aspects of incontinence--a pilot study. Int Urogynecol J Pelvic Floor Dysfunct (1999) 0.92
Resistance to antiretroviral therapy among patients in Uganda. J Acquir Immune Defic Syndr (2001) 0.91
Maternal perception of fetal motor activity. Br Med J (1979) 0.90
Cellular proliferation in the female lower urinary tract with reference to oestrogen status. BJOG (2001) 0.90
Surgery of urinary incontinence. Clin Obstet Gynaecol (1978) 0.89
Urilos: the practical detection of urine loss. Am J Obstet Gynecol (1977) 0.89
Design of a urodynamic questionnaire. Br J Urol (1978) 0.89
Drugs acting on the bladder and urethra. Br Med J (1978) 0.89
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapy. J Infect Dis (2000) 0.88
Is there an irritable bladder in the irritable bowel syndrome? Br J Obstet Gynaecol (1997) 0.88
Clinical and urodynamic effects of anterior colporrhaphy and vaginal hysterectomy for prolapse with and without incontinence. Br J Obstet Gynaecol (1982) 0.88